At Insider Monkey, we think that an investor can beat the market by imitating smart moves of big hedge funds into the top pick they are bullish on. We......
(read more)November 14 - Hedge Funds, News - Comments
We wrote recently about Qlt Inc (NASDAQ:QLTI) entering into an Agreement and Plan of Merger with its wholly-owned indirect subsidiary, Isotope Acquisition......
(read more)September 23 - Hedge Funds, News - Comments
Back in June, Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Qlt Inc. and the latter’s subsidiary, Isotope Acquisition Corp., entered into an Agreement......
(read more)September 14 - Hedge Funds, News - Comments
In June, Qlt Inc (NASDAQ:QLTI) signed an Agreement and Plan of Merger with its wholly-owned indirect subsidiary, Isotope Acquisition Corp., and Aegerion......
(read more)September 14 - Hedge Funds, News - Comments
An amended 13D filing with the Securities and Exchange Commission showed that Kevin Kotler‘s Broadfin Capital has acquired more shares of Recro......
(read more)August 18 - Hedge Funds, News - Comments
Though 2016 hasn’t been great for the overall hedge fund industry so far, it is turning out to be an especially terrible year for biotech-focused......
(read more)April 6 - Hedge Fund Analysis, Hedge Funds, News - Comments
Kevin Kotler‘s Broadfin Capital has filed a Form 13G disclosing an enlarged position of 1.46 million shares of Nevro Corp (NYSE:NVRO). The holding......
(read more)March 2 - Hedge Funds, News - Comments
Although the average hedge fund has been struggling to beat broader market benchmarks in recent years, the hedge fund industry as a whole has been constantly......
(read more)January 29 - Hedge Funds, News - Comments
At Insider Monkey, we focus mainly on the 13F filings of around 730 hedge funds and other institutional investors, in order to identify trading opportunities......
(read more)December 29 - Hedge Funds, News - Comments
Some bright minds of the finance world believe that shareholder activism has surged in recent years because of increased market efficiency. Hedge funds......
(read more)December 16 - Hedge Funds, News - Comments
Most hedge funds and other money managers tracked by Insider Monkey have not submitted their 13F filings for the September quarter just yet. These public......
(read more)November 4 - Hedge Fund Analysis, Hedge Funds, News - Comments
The battle between Broadfin Capital and the Board of Cardica, Inc. (NASDAQ:CRDC) is heating up. As promised in a recent letter, Broadfin Capital and manager......
(read more)October 5 - Hedge Funds, News - Comments
According to a recent 13G form filed with the Securities and Exchange Commission Kevin Kotler‘s (pictured) Broadfin Capital has added 1.18 million......
(read more)September 25 - Hedge Funds, News - Comments
Kevin Kotler‘s healthcare fund Broadfin Capital, the top performing fund in our database this year based on the calculated returns of its public......
(read more)September 14 - Hedge Funds, News - Comments
Both Antares Pharma Inc (NASDAQ:ATRS) and Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) recently had their names attached to 13G forms, as two hedge......
(read more)September 10 - Hedge Funds, News - Comments
As disclosed in a Schedule 13G filing with the U.S. Securities and Exchange Commission, Kevin Kotler’s Broadfin Capital holds an ownership stake of......
(read more)August 13 - Hedge Funds, News - Comments
According to two recent filings with the Securities and Exchange Commission, Kevin Kotler‘s (pictured) Broadfin Capital and Roberto Mignone‘......
(read more)July 23 - Hedge Funds, News - Comments
Kevin Kotler’s Broadfin Capital LLC, one of the leading healthcare-focused hedge funds, disclosed its ownership of nearly 1.48 million shares in Medgenics......
(read more)July 19 - Hedge Funds, News - Comments
Kevin Kotler’s Broadfin Capital has filed a 13D with the Securities and Exchange Commission regarding its stake in Recro Pharma Inc. (NASDAQ:REPH).......
(read more)July 16 - Hedge Funds, News - Comments
Broadfin Capital, led by Kevin Kotler, has initiated a new position in QLT Inc. (USA) (NASDAQ:QLTI). In a new filing with the U.S. Securities and Exchange......
(read more)June 29 - Hedge Funds, News - Comments
According to a recent 13G form filed with the Securities and Exchange Commission, Kevin Kotler‘s Broadfin Capital has initiated a stake in ContraFect......
(read more)June 22 - Hedge Funds, News - Comments
Broadfin Capital, LLC is a New York-based hedge fund, whose $1.28-billion equity portfolio is invested in healthcare companies. Kevin Kotler, a University......
(read more)June 1 - Hedge Funds, News - Comments
Kingdon Capital Management, a New-York based hedge fund, was founded by Mark E. Kingdon in 1983. Prior to this, he worked for AT&T and Century Capital......
(read more)April 16 - Hedge Funds, News - Comments
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross......
(read more)April 16 - Hedge Funds, News - Comments
Kevin Kotler‘s Broadfin Capital has disclosed raising its passive stake in the micro-cap oncology biotechnology company Ignyta Inc (NASDAQ:RXDX).......
(read more)March 25 - Hedge Funds, News - Comments
In two separate filings today Kevin Kotler‘s Broadfin Capital has revealed increasing its passive stake in Zogenix, Inc. (NASDAQ:ZGNX) to 10.74......
(read more)March 19 - Hedge Funds, News - Comments
James E. Flynn’s Deerfield Management entered a new position in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) this week. According to the 13G Form......
(read more)February 10 - Hedge Funds, News - Comments
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over. In filings with the SEC that were revealed over the last......
(read more)February 9 - Hedge Funds, News - Comments
Kevin Kotler’s Broadfin Capital and James Flynn’s Deerfield Management have both initiated passive stakes in Alcobra Ltd (NASDAQ:ADHD). As......
(read more)January 20 - Hedge Funds, News - Comments
Digimarc Corp (NASDAQ:DMRC) and Eleven Biotherapeutics Inc (NASDAQ:EBIO) are two companies on which two funds have been bullish recently. Richard Mashaal......
(read more)December 3 - Hedge Funds, News - Comments
Mark Kingdon’s Kingdon Capital recently disclosed an increase in its exposure to Dipexium Pharmaceuticals Inc (NASDAQ:DPRX). Following the addition......
(read more)December 1 - Hedge Funds, News - Comments
Kevin Kotler‘s New York-based fund Broadfin Capital has boosted its position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR). In a new filing with......
(read more)November 7 - Hedge Funds, News - Comments
Kevin Kotler’s Broadfin Capital doesn’t want to hear any more excuses from the Board of Cardica, Inc. (NASDAQ:CRDC) for under-performance, it want......
(read more)October 23 - Hedge Funds, News - Comments
Stephen Dubois’ Camber Capital Management is again increasing its stakes in Universal American Corporation (NYSE:UAM). Camber Capital Management’s......
(read more)October 20 - Hedge Funds, News - Comments
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness. Not only did Steve Cohen’s Point72 Asset Management disclose......
(read more)October 15 - Hedge Funds, News - Comments
Life science is turning out to be an industry sector that most hedgies are convinced will outperform in the near future. In the last few days we have......
(read more)October 15 - Hedge Funds, News - Comments
Last Friday, Kevin Kotler’s Broadfin Capital disclosed a marked increase (of almost 70%) in its exposure to Anthera Pharmaceuticals Inc (NASDAQ:ANTH......
(read more)October 6 - Hedge Funds, News - Comments
According to a recent filing with the Securities and Exchange Commission, Altai Capital, run by Rishi Bajaj, Toby Symonds and Steve Tesoriere, has increased......
(read more)September 16 - Hedge Funds, News - Comments
In a recent filing with the Securities and Exchange Commission, Broadfin Capital has disclosed a letter sent to the Board of Directors of Cardica,......
(read more)September 12 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, has boosted its position in Horizon Pharma Inc. (NASDAQ:HZNP), a new filing with the U.S. Securities......
(read more)August 11 - Hedge Funds, News - Comments
Kevin Kotler and his fund, Broadfin Capital, have further boosted their holding of Cardica, Inc. (NASDAQ:CRDC) stock. According to a recent filing with......
(read more)July 25 - Hedge Funds, News - Comments
Kevin Kotler is bullish on Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and has decided to boost his fund’s investment in the stock. Kotler’......
(read more)July 22 - Hedge Funds, News - Comments
Israel Englander and Millennium Management have further decreased their stake in Liberator Medical Holdings Inc (NYSEMKT:LBMH) and have sold 175,000......
(read more)June 27 - Hedge Funds, News - Comments
RA Capital Management, managed by Peter Kolchinsky, has sold 800,000 shares of Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) in two transactions for about......
(read more)June 25 - Hedge Funds, News - Comments
Stephen Dubois‘ Camber Capital Management revealed a new stake in Cardica, Inc. (NASDAQ:CRDC). According to a recent 13G filing, the fund now......
(read more)April 25 - Hedge Funds, News - Comments
In three recent filings, Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals......
(read more)April 17 - Hedge Funds, News - Comments
A new filing with the SEC, Kevin Kotler and his hedge fund Broadfin Capital revealed new stake in Dipexium Pharmaceuticals, Inc (NASDAQ:DPRX). In......
(read more)April 9 - Hedge Funds, News - Comments
A new filing with the SEC revealed, Kevin Kotler and his hedge fund Broadfin Capital revealed a trimmed stake in MELA Sciences, Inc (NASDAQ:MELA).......
(read more)April 4 - Hedge Funds, News - Comments
In a couple of new filings with the SEC, Hal Mintz‘s Sabby Management disclosed adding two companies to its equity portfolio: Bioline RX Ltd (NASDAQ......
(read more)March 17 - Hedge Funds, News - Comments
Broadfin Capital, managed by Kevin Kotler, has disclosed in a new filing with the U.S. Securities and Exchange Commission holding shares of Recro Pharma......
(read more)March 13 - Hedge Funds, News - Comments
